from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3710/leuA

LFCtreatmentdescriptionclass of inhibitor

0.843

Amikacinug/mL Amikacintranslation

1.323

Cap5-10ug/mL Capreomycintranslation

1.316

Rox10-50 ug/mL Roxithromycintranslation

0.126

SM2-5 ug/mL Streptomycintranslation

1.664

Tet5-10 ug/mL Tetracyclinetranslation

0.453

Rif0.2-5ug/mL Rifampicintranscription

-0.876

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.679

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.792

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.281

CPZ10-50 ug/mL Chlorpromazinerespiration

3.084

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.079

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.794

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.314

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.376

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.727

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.471

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.482

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.692

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.654

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.603

KCN5-20 ug/mL Potassium cyaniderespiration

1.417

NaN30.2-2 mM Sodium aziderespiration

0.667

Nigericin50 uM Nigericinrespiration

0.217

TRC10-150 ug/mL Triclosanrespiration

0.515

TRZ10-25 ug/mL Thioridazinerespiration

0.582

Valinomycin0.5-10 uM Valinomycinrespiration

-0.331

ZnSO42 mM ZnSO4respiration

0.841

menadione6-10 ug/mL Menadionerespiration

-0.403

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.546

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.700

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.419

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.886

NRP_1Non-replicating persistence stage 1dosRassociated

-0.141

Amp0.2mg/mL AmpicillincellWall

-0.285

Cephalexin20-100 ug/mL CephalexincellWall

-0.793

Cerulenin0.32-5 ug/mL CerulenincellWall

0.336

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.074

EMB10-20 ug/mL EthambutolcellWall

-0.631

Eta12-40 ug/mL EthionamidecellWall

-0.768

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.295

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.711

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.143

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.041

BZA0.12 mg/mL BenzamidearomaticAmides

-0.264

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.544

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.168

H2O24 mM hydrogen peroxideDNAdamaging

-0.760

Levo10 ug/mL LevofloxacinDNAdamaging

-0.383

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.039

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.046

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.491

UVUV-irradiationDNAdamaging

0.164

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.977

Antimycin12.5-50 ug/mL Antimycin A?

-0.958

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.084

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.541

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.890

PA8240.2-2 ug/mL PA-824?

1.901

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.045

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.437

Verapamil50 uM Verapamil?

-0.594

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.134

methoxatin10-20 ug/mL Methoxatin?